Drawing based on the label description. No photo yet.
Cipla 031150mg pill
Pill with imprint Cipla 031150mg is red, capsule, 20 mm and has been identified as Nilotinib 150 mg. It is used for accelerated phase myeloid leukemia, chronic-phase myeloid leukemia and gastrointestinal stromal tumors. It is supplied by Cipla USA Inc.
Nilotinib 150 mg
- Imprint
- Cipla 031150mg
- Strength
- 150 mg
- Used for
- Accelerated phase myeloid leukemia, chronic-phase myeloid leukemia and gastrointestinal stromal tumors
- Color
- Red
- Shape
- Capsule / oblong
- Size
- 20 mm
- Score
- No score line
- Form
- Capsule
- Manufacturer
- Cipla USA Inc
- Drug class
- Cancer medicine (kinase inhibitor)
- NDC
- 69097-031, 69097-031-17, 69097-031-56, 69097-031-74, 69097-031-76, 69097-031-73, 69097-031-91
Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .
Report a mistake
What is Nilotinib used for?
Nilotinib is used for accelerated phase myeloid leukemia, chronic-phase myeloid leukemia and gastrointestinal stromal tumors.
- Medicine type
- Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label
Adult Patients With Newly Diagnosed Ph+ CML-CP
Nilotinib Capsules is indicated for the treatment of adult patients with newly diagnosed Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase.
Additional pediatric use information is approved for Novartis Pharmaceuticals Corporation’s Tasigna ® (nilotinib) capsules. However, due to Novartis Pharmaceuticals Corporation’s marketing exclusivity rights, this drug product is not labeled with that pediatric information.
Adult Patients With Resistant or Intolerant Ph+ CML-CP and CML-AP
Nilotinib Capsules is indicated for the treatment of adult patients with chronic phase and accelerated phase Philadelphia chromosome positive chronic myelogenous leukemia (Ph+ CML) resistant or intolerant to prior therapy that included imatinib.
Additional pediatric use information is approved for Novartis Pharmaceuticals Corporation’s Tasigna ® (nilotinib) capsules. However, due to Novartis Pharmaceuticals Corporation’s marketing exclusivity rights, this drug product is not labeled with that pediatric information.
From the FDA-approved label on DailyMed (published Sep 30, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your pill? Check every detail
- Your pill shows Cipla 031150mg. The parts can be split between the two sides, so turn the pill over and check both.
- It is red, capsule, 20 mm.
- Its score line and coating match the details on this page.
- It came from a pharmacy package that names the same drug.
According to its label, this product is no longer being made or sold.
Ingredients
Active: Nilotinib
Inactive: Silicon Dioxide, Crospovidone, Lactose Monohydrate, Magnesium Stearate, Polysorbate 80, Magnesium Aluminometasilicate, Gelatin, Titanium Dioxide, Ferric Oxide Red, Ammonia, Ferrosoferric Oxide, Propylene Glycol, Potassium Hydroxide, Shellac
Pills that look similar but are different drugs
Same color and shape, different medicine. This is why the imprint matters.
-
G443 G443
Dantrolene Sodium 100 mg
Red & yellow, capsule, 19 mm
Used for multiple sclerosis and muscle stiffness (spasticity)
-
435
Mesalamine 800 mg
Red, capsule, 19 mm
Used for ulcerative colitis and proctitis
-
AMNEAL 778
Budesonide 3 mg
Gray & red, capsule, 19 mm
Used for inflammatory bowel disease and year-round allergies
-
LU E02
Rifampin 300 mg
Red, capsule, 19 mm
Used for tuberculosis (TB) and brucellosis
-
PGC F04
Cycloserine 250 mg
Gray & red, capsule, 20 mm
Used for urinary tract infections (UTIs) and tuberculosis (TB)
-
93 3129 93 3129
Disopyramide Phosphate 150 mg
Brown & red, capsule, 19 mm
Used for atrial fibrillation (irregular heartbeat) and atrial flutter
Other Nilotinib pills
- RDY 150 Nilotinib 150 mg Red, capsule, 19 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- MN4 Nilotinib 150 mg Red, capsule, 19 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- H 23 Nilotinib 150 mg Pink, capsule, 19 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- NVR BCR Nilotinib 150 mg Red, capsule, 22 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- APO N150 Nilotinib 150 mg Red, capsule, 19 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- N12 Nilotinib 150 mg Red, capsule, 19 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- RDY Nilotinib Hydrochloride Monohydrate 150 mg Red, capsule Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- RDY 200 Nilotinib 200 mg Yellow, capsule, 21 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia